A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C

NCT00940420 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2695

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Copegus (ribavirin)
DRUG: Copegus (ribavirin)
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: peginterferon alfa-2a [Pegasys]

Sponsor

Hoffmann-La Roche